Guggenheim Capital
PLXP

Guggenheim Capital’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

Guggenheim Capital’s Portfolio PLXP Stock Details PLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-3,858
Closed -$448K – 3004
2016
Q3 		$448K Sell
3,858
-884
-19% -$86.2K ﹤0.01% 2426
2016
Q2 		$376K Sell
4,742
-68
-1% -$5.89K ﹤0.01% 2469
2016
Q1 		$366K Sell
4,810
-428
-8% -$27.2K ﹤0.01% 2483
2015
Q4 		$469K Buy
+5,238
New +$503K ﹤0.01% 2480

Other funds holding PLXP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AIM
Acrospire Investment Management Chicago, Illinois $107M AUM 37.25% 1-Year Est. Return
BlackRock Fund Advisors
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Middleton & Co
Middleton & Co Boston, Massachusetts $942M AUM 19.03% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Tower Research Capital (TRC)
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Guggenheim Capital's PLXP Position: Q4 2016 in Review

Guggenheim Capital sold out of PLx Pharma Inc. Common Stock (PLXP) in Q4 2016, closing a stake of 3,858 shares — an estimated $448K sold.

Guggenheim Capital first reported a position in PLXP in Q4 2015 and held it in 4 quarters. The position peaked at $469K in Q4 2015. 19 funds tracked by Wall St. Rank hold PLXP as of Q4 2016.

  • Guggenheim Capital reported no remaining PLx Pharma Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
  • Guggenheim Capital sold 3,858 PLx Pharma Inc. Common Stock shares in Q4 2016, an estimated $448K.
  • Guggenheim Capital first reported a position in PLx Pharma Inc. Common Stock in Q4 2015 and held it in 4 quarters.
  • Guggenheim Capital's PLx Pharma Inc. Common Stock position peaked at $469K in Q4 2015.
  • 19 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q4 2016.

Based on Guggenheim Capital's 13F filing for Q4 2016, filed 14 Feb 2017.